Archive for the ‘Atrial Fibrillation (A-Fib)’ Category

Study: Cannabis Use Associated With Lower Risk Of Atrial Fibrillation Among Patients Hospitalized For Heart Failure

Cannabis Use Lower Risk Of Atrial FibrillationEnglewood, NJ: Cannabis exposure is associated with lower instances of atrial fibrillation (arrhythmia) in patients hospitalized for heart failure, according to data published in the American Journal of Cardiology.

A team of investigators from Seton Hall University, the University of Alabama at Birmingham, and elsewhere assessed the relationship between cannabis exposure and atrial fibrillation in a cohort of nearly four million patients hospitalized in 2014 for heart failure.

Compared to matched controls, “Cannabis users have lower odds of AF [than do] nonusers, which was not explained by co-morbid conditions, age, insurance type, [or] socioeconomic status,” authors concluded.

A prior analysis by the team similarly reported that cannabis exposure lowered the risk of atrial fibrillation and also reduced in-hospital mortality in heart failure patients.

Other studies have similarly reported that marijuana-exposed patients are less likely than non-users to die when hospitalized for burns and other forms of severe trauma, certain types of orthopedic surgeries, and traumatic brain injury.

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Relation of cannabis use and atrial fibrillation among patients hospitalized for heart failure,” appears in the American Journal of Cardiology.

Advertisements
Marijuana Use for HeartBergenfield, NJ: Heart failure patients with a history of cannabis use possess reduced odds of in-hospital mortality compared to similarly matched controls, according to data published online in the journal Circulation.

Investigators assessed data from over six million heart failure patients over a seven-year period. Patients with a history of cannabis use were less likely to suffer from atrial fibrillation (irregular heartbeat), experienced shorter hospital stays, and were less likely to die during hospitalization as compared to non-users.

“Our study showed that cannabis use lowered the odds of atrial fibrillation in patients with heart failure,” authors concluded. “There was also reduced in-hospital mortality among patients admitted for the primary diagnosis of heart failure in DU (cannabis dependent users) and NDU (non-dependent cannabis users) which was not explained by comorbid conditions and demographic data. This study provides important opportunity to explore the preventive mechanism of cannabis on atrial fibrillation and its therapeutic potential in heart failure patients.”

Prior studies have similarly reported increased survival rates among marijuana-positive patients hospitalized for traumaTBI (traumatic brain injury), and heart attacks.

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Among patients with heart failure, cannabis is associated with reduced occurrence of atrial fibrillation and in-hospital mortality: Evidence from the Nationwide Survey 2007-2014.”